Download our Application Note “Advantages of VHH in bi-specifics”
To learn more about the application of VHHs in bi-specifics, we have condensed our expertise into this downloadable Application Note.
Abstract:
The Application Note includes:
- a review of the bi-specific mechanisms of action, key targets and our clinical development pipeline
- a summary of Isogenica’s multi-specific plug-and-play platform
- exemplar data using our synthetic VHH antibodies
Who should read this:?
- Researchers in antibody discovery, engineering and development
- Thought leaders in antibody development or oncology
- Those curious to learn more about VHHs in oncology
